Skip to main content
. 2022 Sep 16;26:279. doi: 10.1186/s13054-022-04168-w

Table 2.

Details of study drug administered

Remimazolam
(n = 30)
Propofol
(n = 30)
P value
Duration of study drug infusion, h 55.0 (28.3 − 102.0) 41.0 (24.8 − 74.3) 0.255
Dose of study drug, mg/kg/h 0.18 (0.15 − 0.22) 1.98 (1.40 − 2.91)
Dose of remifentanil, μg/kg/h 4.70 (0.88) 4.55 (1.12) 0.550
Dexmedetomidine infusion
 Ever useda 7 (23.3%) 6 (20.0%) 0.754
 Duration, h 30.0 (25.0 − 41.0) 28.0 (9.3 − 91.3) 0.775
 Dose, μg/kg/h 0.51 (0.19) 0.37 (0.16) 0.204

Data are count (%), mean (SD) or median (interquartile range)

aThe number of patients who received at least one dose of dexmedetomidine